In an action brought under the Patented Medicines (Notice of Compliance) Regulations, Boehringer Ingelheim (Canada) Ltd, Boehringer Ingelheim Pharma GMBH & Co KG, and Boehringer Ingelheim International GMBH (collectively, “BI”), redacted information from documents before they were disclosed to Pharmascience Inc (“Pharmascience”).